强化降压与快速出血性颅内出血患者血肿增长减少相关
该研究为ATACH-2随机对照试验的探索性分析,纳入940例自发性颅内出血患者,其中567例符合快速出血定义(基线血肿体积/发病至CT时间>5 ml/hr)。在快速出血患者中,强化降压与血肿增长发生率显著降低相关(20.6% vs 31.0%,p=0.005);在发病2小时内治疗的亚组中,强化降压与功能独立改善相关(OR=1.98,95%CI=1.06-3.69,p=0.031)。
要点
- 快速出血定义为颅内出血体积与发病至CT时间之比>5 ml/hr,本研究567例(60.3%)符合。
- 快速出血患者中,强化降压组血肿增长发生率20.6%,低于对照组的31.0%(p=0.005)。
- 发病2小时内治疗的快速出血亚组中,强化降压与功能独立改善相关(OR=1.98,95%CI=1.06-3.69)。
核心结论
- 研究结果提示,早期使用强化降压可能减少快速出血患者的血肿增长并改善预后。
研究设计与样本
- 对ATACH-2随机对照试验数据进行的探索性分析,共纳入940例患者(平均年龄62.1岁,61.5%为男性)。
- 研究限定为快速出血性颅内出血,定义为颅内出血体积/发病至CT时间>5 ml/hr;血肿增长定义为基线至24小时血肿体积增加>33%。
主要发现
- 940例患者中214例(22.8%)发生血肿增长;567例(60.3%)符合快速出血定义,其基线颅内出血体积与就诊时间之比至少为5 ml/hr。
- 在快速出血患者中,强化降压与血肿增长率显著降低相关(20.6% vs 31.0%,p=0.005)。
- 在发病2小时内接受治疗的266例(46.9%)快速出血患者亚组中,强化降压与功能独立改善相关(OR=1.98,95%CI=1.06-3.69,p=0.031)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with spontaneous intracerebral hemorrhage (ICH) at the highest risk of hematoma growth are those with the most potential to benefit from anti-expansion treatment. Large clinical trials have not definitively shown a clear benefit of blood pressure (BP) reduction. We aim to determine whether intensive blood pressure reduction could benefit patients with fast bleeding ICH. METHODS: An exploratory analysis of data from the Antihypertensive Treatment of Acute Cerebral Hemorrhage 2 (ATACH-2) randomized controlled trial was performed. In order to capture not just early bleeding (even if a small amount), but the rate of bleeding (ml/hour), we restricted the study to "Fast bleeding ICH," defined as an ICH volume/onset to computed tomography (CT) time >5 ml/hr. Hematoma growth, as defined as an increase of hematoma volume > 33% between baseline and 24 hours. RESULTS: A total of 940 patients were included (mean age = 62.1 years, 61.5% men), of whom 214 (22.8%) experienced hematoma expansion. Of these, 567 (60.3%) met the definition of "fast bleeding" with baseline ICH volume/time to presentation of at least 5 ml/hr. Intensive BP reduction was associated with a significantly lower rate of hematoma growth in fast bleeding patients (20.6% vs 31.0%, p = 0.005). In a subgroup of 266 (46.9%) fast-bleeding patients who received treatment within 2 hours after symptom onset, intensive BP lowering was associated with improved functional independence (odds ratio [OR] = 1.98, 95% confidence interval [CI] = 1.06-3.69, p = 0.031). INTERPRETATION: Our results suggest that early use of intensive BP reduction may reduce hematoma growth and improve outcome in fast bleeding patients. ANN NEUROL 2024;95:129-136.
引用
- Li Q, Morotti A, Warren A, et al. Intensive Blood Pressure Reduction is Associated with Reduced Hematoma Growth in Fast Bleeding Intracerebral Hemorrhage. Ann Neurol. 2023. PMID: 37706569. doi:10.1002/ana.26795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。